Bluefin Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-341,250
| Closed | -$51.6M | – | 458 |
|
|
2022
Q3 | $51.6M | Buy |
+341,250
| New | +$51.6M | 4.66% | 5 |
|
|
2021
Q1 | – | Sell |
-19,690
| Closed | -$1.69M | – | 747 |
|
|
2020
Q4 | $1.69M | Buy |
+19,690
| New | +$1.69M | 0.1% | 118 |
|
|
2020
Q3 | – | Sell |
-31,969
| Closed | -$2.34M | – | 72 |
|
|
2020
Q2 | $2.34M | Buy |
31,969
+21,475
| +205% | +$1.57M | 0.2% | 53 |
|
|
2020
Q1 | $357K | Sell |
10,494
-155,251
| -94% | -$5.28M | 0.05% | 121 |
|
|
2019
Q4 | $9.02M | Buy |
+165,745
| New | +$9.02M | 0.6% | 39 |
|
|
2019
Q2 | – | Sell |
-7,366
| Closed | -$379K | – | 358 |
|
|
2019
Q1 | $379K | Buy |
+7,366
| New | +$379K | 0.05% | 123 |
|